1
|
Husson O, Drabbe C, Schuster K, van Kampen P, Koops C, Weidema M, Davidson R, Wartenberg M, Artzner E, Gonzato O, Fernandez N, Kasper B, Pilgermann K, Wilson R, van der Graaf WTA, van Oortmerssen G. Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership. ESMO Open 2022; 7:100509. [PMID: 35714479 PMCID: PMC9271500 DOI: 10.1016/j.esmoop.2022.100509] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Revised: 05/03/2022] [Accepted: 05/10/2022] [Indexed: 12/02/2022] Open
Abstract
Background Research in sarcomas has historically been the domain of scientists and clinicians attempting to understand the disease to develop effective treatments. This traditional approach of placing scientific rigor before the patient’s reality is changing. This evolution is reflected in the growth of patient-centered organizations and patient advocacy groups that seek to meaningfully integrate patients into the research process. The aims of this study are to identify the unanswered questions regarding sarcomas (including gastrointestinal stromal tumors and desmoid fibromatosis) from patient, carer, and clinical perspectives and examine how patients and carers want to be involved in sarcoma research. Methods The Patient-Powered Research Network of Sarcoma Patients EuroNet set up a Priority Setting Partnership (PSP) in collaboration with stakeholders from the sarcoma research field. This PSP is largely based on the James Lind Alliance methodology. Results In total, 264 sarcoma patients (73%) and carers (27%) from all over the world participated in the online survey and covered the full spectrum of sarcomas. The topics mentioned were labeled in accordance with the Common Scientific Outline of the International Cancer Research Partnership and lists for potential research topics, advocacy topics, and requests for information were constructed. With regard to patient and carer involvement, 64% were very willing to be actively involved and mainly in the following areas: sharing perspectives, discussing patient-clinician interactions, and attending research meetings. Conclusions The first results of this sarcoma PSP identified important research questions, but also important topics for patient advocacy groups and further improvement of information materials. Sarcoma patients and carers have a strong wish to be involved in multiple aspects of sarcoma research. The next phase will identify the top 10 research priorities per tumor type. These priorities will provide guidance for research that will achieve greatest value and impact. The results from this international sarcoma Priority Setting Partnership (PSP) identified important research questions. This PSP also identified important topics for patient advocacy and requests for information. Sarcoma patients and carers have a strong wish to be involved in multiple aspects of sarcoma research. The next phase of this PSP will aim to prioritize the research questions per tumor type.
Collapse
Affiliation(s)
- O Husson
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Surgical Oncology, Erasmus Cancer Institute, Rotterdam, the Netherlands; Division of Clinical Studies, Institute of Cancer Research, Sutton, London, UK
| | - C Drabbe
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus Cancer Institute, Rotterdam, the Netherlands
| | - K Schuster
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany
| | - P van Kampen
- Dutch Sarcoma Patient Platform, Utrecht, the Netherlands
| | - C Koops
- Dutch Sarcoma Patient Platform, Utrecht, the Netherlands
| | - M Weidema
- Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
| | | | - M Wartenberg
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany; German Sarcoma Foundation, Wölfersheim, Germany; National Center for Tumor Diseases Germany, Heidelberg, Germany
| | - E Artzner
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany
| | - O Gonzato
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany; Trust Paola Gonzato-Rete Sarcoma, Italy
| | - N Fernandez
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany
| | - B Kasper
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany; German Sarcoma Foundation, Wölfersheim, Germany; Sarcoma Unity, University of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center, Mannheim, Germany
| | - K Pilgermann
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany
| | - R Wilson
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany; Sarcoma UK, London, UK
| | - W T A van der Graaf
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus Cancer Institute, Rotterdam, the Netherlands
| | - G van Oortmerssen
- Sarcoma Patients EuroNet (SPAEN), Wölfersheim, Germany; Dutch Sarcoma Patient Platform, Utrecht, the Netherlands.
| |
Collapse
|
2
|
Straßburg J, Koops C, Pereszlenyi A, Sklenar S, Krüll M, Eggeling S. Sekundärer Pneumothorax bei COPD – Spätkomplikation der endobronchialen Ventiltherapie. Pneumologie 2011. [DOI: 10.1055/s-0031-1297386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
3
|
Koops C, Straßburg J, Morgen R, Sklenar S, Pereszlenyi A, Eggeling S. Katamenialer Pneumothorax – Eine Erkrankung des Zwerchfells? Pneumologie 2011. [DOI: 10.1055/s-0031-1297379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|